Cantor Fitzgerald reaffirmed an overweight rating on Braze.
3 reports, 1 independent
Updated Aug 29
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald reaffirmed an overweight rating on Braze.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Insider selling by Braze CTO Jon Hyman reported alongside rating updates.1 source
Cantor Fitzgerald reaffirmed an overweight rating on Braze.1 source
Keep exploring
The entities involved
-
Braze
American software company
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald reiterated an Overweight rating for aTyr Pharma on August 20, 2025.
- Cantor Fitzgerald set a neutral rating on Merck & Co., Inc. on September 12, 2026.
- Cantor Fitzgerald initiated an overweight rating for Bentley Systems.
- Cantor Fitzgerald reiterated an Overweight rating on Amazon stock.
- Cantor Fitzgerald and Citigroup issued rating updates, while MarketBeat reported research notes on Quince Therapeutics.
Coverage
Newest first; wire copies grouped- themarketsdaily.com
- themarketsdaily.comBraze (NASDAQ:BRZE) Shares Gap Up – Time to Buy?